Mr. Stanley has been with the company since 2011. He has 22 years of experience in the FDA regulated pharmaceutical / biotech industry, including responsibility for global supply chain management for Spectrum Pharmaceuticals, where he saved the company $2 million per year in operating expenses. Prior to this, he held management positions at Dendreon Corp. and IDEC Pharmaceuticals. Mr. Stanley has extensive expertise in CMC, including oversight of GMP/GLP/GCP (GxP) systems. He has served as Quality/Validation lead for four different companies for multiple FDA inspections. Mr. Stanley has been involved in the development of numerous early and late-stage pharmaceutical/biotech products, as well as BLA/NDA submissions and marketed product launches.